What is Bristol-Myers Squibb's revenue?

Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.

Is Bristol-Myers Squibb profitable?

Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.

What is Bristol-Myers Squibb's earnings per share?

Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.

Where does Bristol-Myers Squibb's income statement data come from?

Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bristol-Myers Squibb BMY Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$48.48B+0.6%	$48.19B+0.3%	$48.03B+0.7%	$47.7B+0.1%	$47.64B-1.4%
Total cost of revenue	$14.33B+2.8%	$13.94B-4.9%	$14.65B+3.4%	$14.17B+0.7%	$14.07B+0.7%
Gross profit	$34.16B-0.3%	$34.26B+2.6%	$33.38B-0.4%	$33.53B-0.1%	$33.57B-2.2%
Gross margin	70.5%-0.6pp	71.1%+1.6pp	69.5%-0.8pp	70.3%-0.2pp	70.5%-0.6pp
Research and development	$10.34B+3.9%	$9.95B-5.7%	$10.56B+1.5%	$10.4B-3.0%	$10.72B-3.9%
Selling, general and administrative	$7.3B+0.5%	$7.27B+0.6%	$7.22B-2.6%	$7.42B-2.8%	$7.63B-9.3%
Total costs & expenses	$38.89B+0.1%	$38.87B-2.8%	$40B-2.7%	$41.11B-1.0%	$41.53B-26.7%
Income before income taxes	$9.6B+2.9%	$9.33B+18.7%	$7.86B+22.4%	$6.42B+8.2%	$5.93B+169%
Income tax expense	$2.32B+2.3%	$2.27B+14.3%	$1.99B+30.0%	$1.53B+128%	$671M+21.1%
Net income	$7.28B+3.1%	$7.05B+18.2%	$5.97B+19.9%	$4.98B-6.9%	$5.35B+159%
Net margin	15%+0.4pp	14.6%+2.2pp	12.4%+2.0pp	10.4%-0.8pp	11.2%+29.9pp
Diluted earnings per share	$3.56+3.2%	$3.45+18.2%	$2.92+19.7%	$2.44-7.2%	$2.63+159%
EBITDA	$13.19B-1.1%	$13.34B+4.4%	$12.77B-1.1%	$12.92B-7.8%	$14.01B+1,240%
EBITDA margin	27.2%-0.5pp	27.7%+1.1pp	26.6%-0.5pp	27.1%-2.3pp	29.4%+27.3pp
EBIT	$9.6B+2.9%	$9.33B+18.7%	$7.86B+22.4%	$6.42B+8.2%	$5.93B+169%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's revenue?: Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.
Is Bristol-Myers Squibb profitable?: Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.
What is Bristol-Myers Squibb's earnings per share?: Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.
Where does Bristol-Myers Squibb's income statement data come from?: Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.